CareDx (CDNA) Misses Q4 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to CareDx (CDNA) Misses Q4 EPS by 6c

CareDx Reports Fourth Quarter and Full Year 2021 Results

February 24, 2022 4:01 PM EST

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers -- today reported financial results for the fourth quarter and full year ended December 31, 2021.

Recent Highlights:

Achieved total revenue of $79.2 million for the three months ended December 31, 2021, increasing 35% over prior year fourth quarterDelivered full year revenue of $296.4 million, an increase of 54% compared with full year 2020... More